Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like Pre-Feasibility Study Launched for 10,000pta WA Facility August 19, 2025 Top 10 Iron Ore-producing Countries August 19, 2025 Kobo Resources: Unlocking West Africa’s Untapped Gold Potential August 19, 2025 Graphite Market Update: H1 2025 in Review August 19, 2025 Questcorp Mining Completes 25 Percent of Maiden Drilling... August 19, 2025 Prismo Metals August 18, 2025 Anteros Metals August 18, 2025 Prismo Engages Windfall Geotek for Data Analysis at... August 18, 2025 Apollo Silver Engages CDMG for Marketing Services August 18, 2025 Tech 5: US Government Strikes Big Tech Deal,... August 17, 2025